Drought and food security – Improving decision-support via new technologies and innovative collaboration

n/

Light Emission and Conductance Fluctuations in Electrically Driven and Plasmonically Enhanced Molecular Junctions

Electrically connected and plasmonically enhanced molecular junctions combine the optical functionalities of high field confinement and enhancement (cavity function), and of high radiative efficiency (antenna function) with the electrical functionalities of molecular transport and electrically driven light emission. They are supposed to play a leading role in emerging nanoscale optoelectronic devices; yet, this development is hindered by an insufficient control and understanding of atomic-scale phenomena that govern the optical and electrical behavior of plasmonic nanojunctions under ambient operating conditions. For instance, displacement of a single atom may drastically influence the junction's conductance and its optical near-field distribution. Here, we investigate tunneling-induced light emission from a self-assembled metal-molecule-metal junction embedded in a plasmonic cavity at room-temperature. We find that despite the presence of hundreds of molecules in the junction, electrical conductance and light emission are both highly sensitive to atomic-scale fluctuations - a phenomenology reminiscent of picocavities observed in Raman scattering and of luminescence blinking from photo-excited plasmonic junctions. We present a minimal electrical model that is able to capture all main experimental features. Contrasting with these microscopic fluctuations, the overall plasmonic and electronic functionalities of our devices feature an excellent long-term stability and reproducibility at room temperature and under electrical bias of several volts, allowing for measurements over several months. Our work contributes to the understanding of atomic fluctuations in molecular plasmonic junctions and to the development of more robust and scalable platforms for nanoscale optoelectronics

Medical genetics in developing countries in the Asia-Pacific region: challenges and opportunities

Advances in genetic and genomic technology changed health-care services rapidly in low and middle income countries (LMICs) in the Asia-Pacific region. While genetic services were initially focused on population-based disease prevention strategies, they have evolved into clinic-based and therapeutics-oriented service. Many LMICs struggled with these noncommunicable diseases and were unprepared for the needs of a clinical genetic service. The emergence of a middle class population, the lack of regulatory oversight, and weak capacity-building in medical genetics expertise and genetic counseling services led to a range of genetic services of variable quality with minimal ethical oversight. Some of the current shortcomings faced include the lack of awareness of cultural values in genetic health care, the variable stages of socioeconomic development and educational background that led to increased demand and abuse of genetics, the role of women in society and the crisis of gender selection, the lack of preventive and care services for genetic and birth defects, the issues of gene ethics in medicine, and the lack of understanding of some religious controversies. These challenges provide opportunities for both developing and developed nations to work together to reduce the inequalities and to ensure a caring, inclusive, ethical, and cost-effective genetic service in the region